Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare TSE:HSM CVE:MDX NYSE:PHM NASDAQ:TLT On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeHSMHelius Medical TechnologiesC$0.00C$14.26▼C$40.00C$42.54MN/A3,578 shs930 shsMDXMedX HealthC$0.09-5.6%C$0.08C$0.04▼C$0.10C$22.96M1.26123,405 shs10,000 shsPHMPulteGroup$109.29+1.2%$103.79$88.07▼$149.47$21.90B1.292.05 million shs1.58 million shsTLTiShares 20+ Year Treasury Bond ETF$85.06+0.1%$86.25$83.29▼$101.64$46.24B0.0639.44 million shs61.50 million shs(Almost) Everything You Need To Know About The EV MarketLooking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceHSMHelius Medical Technologies0.00%0.00%0.00%0.00%0.00%MDXMedX Health-5.56%-5.56%-10.53%+30.77%+21.43%PHMPulteGroup-4.36%-0.83%+6.51%+16.24%-7.06%TLTiShares 20+ Year Treasury Bond ETF-0.70%-1.19%-1.53%-3.74%-8.45%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationHSMHelius Medical TechnologiesN/AN/AN/AN/AN/AN/AN/AN/AMDXMedX HealthN/AN/AN/AN/AN/AN/AN/AN/APHMPulteGroup4.9251 of 5 stars3.33.02.51.94.01.73.8TLTiShares 20+ Year Treasury Bond ETFN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceHSMHelius Medical Technologies 0.00N/AN/AN/AMDXMedX Health 0.00N/AN/AN/APHMPulteGroup 2.60Moderate Buy$133.6922.33% UpsideTLTiShares 20+ Year Treasury Bond ETF 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownLatest MDX, TLT, PHM, and HSM Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails7/15/2025PHMPulteGroupOppenheimerSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetOutperform ➝ Outperform$125.00 ➝ $132.007/8/2025PHMPulteGroupWells Fargo & CompanySubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetOverweight ➝ Overweight$120.00 ➝ $125.004/23/2025PHMPulteGroupRoyal Bank Of CanadaSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetSector Perform ➝ Sector Perform$116.00 ➝ $109.004/23/2025PHMPulteGroupUBS GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetBuy ➝ Buy$151.00 ➝ $141.004/23/2025PHMPulteGroupEvercore ISISubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetOutperform ➝ Outperform$161.00 ➝ $165.004/23/2025PHMPulteGroupBarclaysSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetEqual Weight ➝ Equal Weight$100.00 ➝ $98.004/22/2025PHMPulteGroupWedbushSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingOutperform$135.00(Data available from 7/16/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookHSMHelius Medical TechnologiesC$477K0.00N/A5.71C$3.61 per share0.00MDXMedX HealthC$510.56K44.98C$0.00 per share60.00C($0.03) per share-2.83PHMPulteGroup$17.89B1.22$13.76 per share7.94$59.87 per share1.83TLTiShares 20+ Year Treasury Bond ETFN/AN/AN/AN/AN/AN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateHSMHelius Medical TechnologiesN/A-C$11.02N/AN/AN/AN/AN/AN/AN/AMDXMedX Health-C$3.82M-C$0.02N/A∞N/AN/AN/A-220.68%N/APHMPulteGroup$3.08B$14.187.718.080.3316.45%22.86%15.83%7/22/2025 (Estimated)TLTiShares 20+ Year Treasury Bond ETFN/AN/AN/A∞N/AN/AN/AN/AN/ALatest MDX, TLT, PHM, and HSM EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails7/22/2025Q2 2025PHMPulteGroup$2.94N/AN/AN/A$4.42 billionN/A4/22/2025Q1 2025PHMPulteGroup$2.47$2.57+$0.10$2.57$3.86 billion$3.89 billionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthHSMHelius Medical TechnologiesN/AN/AN/AN/AN/AMDXMedX HealthN/AN/AN/AN/AN/APHMPulteGroup$0.880.81%N/A6.21%7 YearsTLTiShares 20+ Year Treasury Bond ETF$3.834.50%N/AN/AN/ALatest MDX, TLT, PHM, and HSM DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date6/30/2025TLTiShares 20+ Year Treasury Bond ETFMonthly$0.32834.47%7/1/20257/1/20257/7/20255/1/2025PHMPulteGroupquarterly$0.220.85%6/17/20256/17/20257/2/20255/30/2025TLTiShares 20+ Year Treasury Bond ETFMonthly$0.31954.5%6/2/20256/2/20256/5/20254/30/2025TLTiShares 20+ Year Treasury Bond ETFMonthly$0.32764.43%5/1/20255/1/20255/6/2025(Data available from 1/1/2013 forward)Compare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioHSMHelius Medical Technologies0.744.203.58MDXMedX HealthN/A0.100.05PHMPulteGroup0.130.800.80TLTiShares 20+ Year Treasury Bond ETFN/AN/AN/ACompare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipHSMHelius Medical TechnologiesN/AMDXMedX Health0.01%PHMPulteGroup89.90%TLTiShares 20+ Year Treasury Bond ETF73.32%Insider OwnershipCompanyInsider OwnershipHSMHelius Medical TechnologiesN/AMDXMedX Health6.23%PHMPulteGroup0.76%TLTiShares 20+ Year Treasury Bond ETFN/ACompare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableHSMHelius Medical Technologies192.32 millionN/ANot OptionableMDXMedX HealthN/A270.17 millionN/ANot OptionablePHMPulteGroup6,793200.43 million198.90 millionOptionableTLTiShares 20+ Year Treasury Bond ETFN/A543.60 millionN/AOptionableMDX, TLT, PHM, and HSM HeadlinesRecent News About These CompaniesGovernor Waller Gets Candid About Fed's Balance Sheet Mismatch And LossesJuly 14 at 1:56 PM | seekingalpha.comTLT: The Upside Could Be Much Bigger Than You ThinkJuly 14 at 9:07 AM | seekingalpha.comA Massive Bear Steepener May Be About To Shock MarketsJuly 13 at 10:00 AM | seekingalpha.comDebt Ceiling Increase Will Allow U.S. Treasury To Resume BorrowingJuly 11, 2025 | seekingalpha.comTrump Beats Estimates And Raises GuidanceJuly 9, 2025 | seekingalpha.comiShares 10-20 Year Treasury Bond ETF declares monthly distribution of $0.3596July 2, 2025 | msn.comTLT: Staying Bullish After Its Latest SurgeJuly 2, 2025 | seekingalpha.comHow And Why I Built A Self-Funded Pension Using US TreasuriesJuly 1, 2025 | seekingalpha.comSemiannual Monetary Policy: Powell Tells Congress Why The Fed Won't Cut Rates NowJune 27, 2025 | seekingalpha.comAre Long-Dated Treasury Bonds A Place For Safety?June 24, 2025 | seeitmarket.comSWeekly Treasury Simulation, June 20, 2025: Peak In One-Month Forward Rates Up 0.14% To 6.16%June 23, 2025 | seekingalpha.comChair Powell Blames Increase In SEP Inflation Expectations On TariffsJune 20, 2025 | seekingalpha.comRFIX: Taking The Bond Bull ETF By The HornsJune 18, 2025 | seekingalpha.comHow The Global Rise In Bond Yields Is Weakening World Central BanksJune 10, 2025 | seekingalpha.comiShares 20+ Year Treasury Bond ETF Experiences Big OutflowJune 7, 2025 | nasdaq.comThe Market’s Silent Warning: What Bonds and Gold Reveal (TLT)...June 6, 2025 | marketbeat.comThe $2 Trillion Warning: How to Fix Your Broken Bond PortfolioJune 4, 2025 | moneymorning.comMiShares 20+ Year Treasury Bond ETF declares monthly distribution of $0.3195June 2, 2025 | msn.comWhat This Bull Got Wrong About BondsMay 29, 2025 | seekingalpha.comTLT: 5% Yield Now Outpaces Equity Earnings Yield, With Higher Term Premium EmbeddedMay 29, 2025 | seekingalpha.comETFs in Focus Amid Japan's Soaring Bond YieldsMay 29, 2025 | zacks.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeMDX, TLT, PHM, and HSM Company DescriptionsHelius Medical Technologies TSE:HSMHelius Medical Technologies, Inc., a neurotechnology company, focuses on developing, licensing, and acquiring non-invasive technologies for the treatment of symptoms caused by neurological disease or trauma. Its product, Portable Neuromodulation Stimulator (PoNS), is a non-implantable investigational medical device intended for use as a short term treatment of gait deficit due to symptoms from multiple sclerosis and balance deficit due to mild-to-moderate traumatic brain injury, as well as to be used in conjunction with supervised therapeutic exercise. The company is headquartered in Newtown, Pennsylvania.MedX Health CVE:MDXC$0.08 -0.01 (-5.56%) As of 12:42 PM EasternMedX Health Corp develops, manufactures, and markets skin related screening tools and phototherapy devices for pain relief and tissue repair in Canada, the United States, and internationally. The company offers SIAscopy, a medical device technology used to scan skin for suspicious moles and lesions; and phototherapeutic medical devices, which use light energy in lower-level laser and LED to provide treatment for pain and tissue damage in the rehabilitation market. It operates DermSecure telemedicine platform that enables the web-based operation of its SIAscopy scanning technology and allows the company to deploy its technology in networks of third-party locations from which patients' mole and lesion images along with other relevant patient information can be connected to specialist physicians for remote assessment. The company was incorporated in 1999 and is headquartered in Mississauga, Canada.PulteGroup NYSE:PHM$109.29 +1.29 (+1.20%) Closing price 03:59 PM EasternExtended Trading$109.30 +0.01 (+0.01%) As of 04:04 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.PulteGroup, Inc., through its subsidiaries, primarily engages in the homebuilding business in the United States. It acquires and develops land primarily for residential purposes; and constructs housing on such land. The company also offers various home designs, including single-family detached, townhomes, condominiums, and duplexes under the Centex, Pulte Homes, Del Webb, DiVosta Homes, John Wieland Homes and Neighborhoods, and American West brand names. In addition, the company arranges financing through the origination of mortgage loans primarily for homebuyers; sells the servicing rights for the originated loans; and provides title insurance policies, and examination and closing services to homebuyers. PulteGroup, Inc. was founded in 1950 and is headquartered in Atlanta, Georgia.iShares 20+ Year Treasury Bond ETF NASDAQ:TLT$85.06 +0.05 (+0.06%) Closing price 03:59 PM EasternExtended Trading$85.08 +0.02 (+0.03%) As of 04:06 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.iShares 20+ Year Treasury Bond ETF (the Fund) is an exchange-traded fund. The Fund seeks to track the investment results of an index composed of United States Treasury bonds with remaining maturities greater than 20 years. The Fund seeks to track the investment results of the Barclays U.S. 20+ Year Treasury Bond Index (the Underlying Index), which measures the performance of public obligations of the United States Treasury that have a remaining maturity of 20 or more years. The Underlying Index includes all publicly-issued the United States Treasury securities that have a remaining maturity of greater than or equal to 20 years. BlackRock Fund Advisors serves as investment adviser of the Fund. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas AMD Just Triggered a Signal Traders Can’t Ignore This ASML Dip Could Be Gone Before You Know It—Don’t Miss Out Rocket Lab Gets New Street-High Price Target from Citi Pelosi Makes Big Bet on Broadcom—Here’s Why It Matters 3 Analysts Set $600 Target Ahead of Microsoft Earnings Salesforce Stock Set for 30% Upside to Reach New Highs JPMorgan Q2 Results Affirm Dividend, Buybacks, & Growth NVDA Greenlight: China H20 Sales Spark 50% Rally Potential Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
